|
- Adult cord blood transplant results in comparable overall survival and . . .
We compared outcomes among adult matched related donor (MRD) patients undergoing peripheral blood stem cell transplantation and adult patients undergoing double unit cord blood transplantation (CBT) at our center between 2010 and 2017
- Concise Review: Umbilical Cord Blood Transplantation: Past, Present . . .
This study reviews the past, present, and future of cord transplantation, including the potential use of single- and double-unit cord blood transplantation in multiple hematological malignancies including leukemia and aggressive lymphomas in light of recent discoveries
- Clinical Outcomes of Umbilical Cord Blood Transplantation Using Ex Vivo . . .
Ex vivo culture strategies have been increasingly evaluated in controlled studies, but their impact on transplantation-related outcomes remains uncertain owing to the small patient numbers in these studies, necessitating an updated systematic review and meta-analysis
- Umbilical cord blood transplantation: Still growing and improving
In this review, we focus on the development of UCBT over the past 30 years, the challenges it faces and the strategies for future improvement, including increasing UCB numbers, cord blood unit selection, conditioning regimens and GVHD prophylaxis for UCBT, and management of complications of UCBT
- Comparative retrospective analysis of cord blood transplantation with . . .
We conducted a retrospective review of data from patients who underwent CBT at our centre from August 2003 to December 2022 Patients undergoing CBT with ATG were matched with those who received HLA-haploidentical haematopoietic stem cell transplantation (haplo-HSCT)
- Cord blood research, banking, and transplantation: achievements . . .
The first hematopoietic transplant in which umbilical cord blood (UCB) was used as the source of hematopoietic cells was performed in October 1988
- Favorable Outcomes after Single Cord Blood Transplantation for Patients . . .
To assess the potential of CB transplantation (CBT) in patients with hematologic malignancies, especially for high-risk patients, we performed a single-institute retrospective analysis and compared the clinical outcomes of CBT with those of HLA-matched sibling and unrelated donor transplantation
- Haplo-cord transplant. Realizing the potential of umbilical cord blood . . .
The combination of cord blood transplant with progenitor cells from partially HLA-matched adult donors (haplo-cord transplant) has been used over the past two decades
|
|
|